Erythrocyte Sedimentation Rate As a Marker for Coronary Heart Disease

Overview

Journal Vasc Health Risk Manag

Publisher Dove Medical Press

Specialty Cardiology & Vascular Diseases

Date 2012 Apr 27

PMID 22536077

Citations 25

Authors

Josef Yayan

Affiliations

Soon will be listed here.

Abstract

Background: Patients with angina pectoris or myocardial infarction frequently present without evidence of cardiac-specific heart enzymes by laboratory analysis or specific pathologic electro-cardiogram findings. The current study analyzed the efficacy of the erythrocyte sedimentation rate as an additional potential indicator for coronary heart disease, the aim being to enable quicker identification of patients with angina pectoris or myocardial infarction so that they can be more rapidly treated.

Methods: Patients with angina pectoris or myocardial infarction who had undergone a heart catheter examination were included in the study. The diagnosis of acute coronary heart disease was made by the physician who performed coronary angiography. Patients without coronary heart disease were used as a control group. The erythrocyte sedimentation rate was measured in all patients. Patients with angina pectoris or myocardial infarction and an inflammatory or tumor disease were excluded.

Results: The erythrocyte sedimentation rate was prolonged in 79 (58.09%) of 136 patients; 69 (50.74%) patients (95% confidence interval ±8.4%, 42.34%-59.14%) had coronary heart disease and a prolonged erythrocyte sedimentation rate. The erythrocyte sedimentation rate was prolonged in ten (7.35%) patients (95% confidence interval ±4.39%, 2.96%-11.74%) without coronary heart disease by coronary angiography. The specificity of the erythrocyte sedimentation rate for coronary heart disease was 70.59% and the sensitivity was 67.65%.

Conclusion: Erythrocyte sedimentation rate may be a useful additional diagnostic criterion for coronary heart disease.

Citing Articles

Use machine learning models to identify and assess risk factors for coronary artery disease.

Zhang M, Wang H, Zhao J PLoS One. 2024; 19(9):e0307952.

PMID: 39240939 PMC: 11379138. DOI: 10.1371/journal.pone.0307952.

Exploring the Correlation between Systemic Inflammatory Markers and Carotid Atherosclerosis Indices in Middle-Aged Adults: A Cross-Sectional Study.

Song J, Hwang J, Ko H, Park J, Hong H, Kim A J Cardiovasc Dev Dis. 2024; 11(3).

PMID: 38535095 PMC: 10971297. DOI: 10.3390/jcdd11030073.

Evaluation of Stability and Accuracy Compared to the Westergren Method of ESR Samples Analyzed at VES-MATIC 5.

Lorubbio M, Diamanti D, Ghiandai A, Pieroni C, Bonini D, Pettinari M Diagnostics (Basel). 2024; 14(5).

PMID: 38473029 PMC: 10930947. DOI: 10.3390/diagnostics14050557.

Relationship Between Red Cell Distribution Width and Oxidative Stress Indexes in Patients with Coronary Artery Disease.

Namazi G, Heidar Beygi S, Vahidi M, Asa P, Bahmani F, Mafi A Rep Biochem Mol Biol. 2024; 12(2):241-250.

PMID: 38317815 PMC: 10838587. DOI: 10.61186/rbmb.12.2.241.

Biomechanical Investigation of Red Cell Sedimentation Using Blood Shear Stress and Blood Flow Image in a Capillary Chip.

Kang Y Micromachines (Basel). 2023; 14(8).

PMID: 37630130 PMC: 10456426. DOI: 10.3390/mi14081594.

References

Peppes V, Rammos G, Manios E, Koroboki E, Rokas S, Zakopoulos N . Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: a hospital-based, prospective study in Greek patients. Clin Interv Aging. 2009; 3(4):699-710. PMC: 2682402. DOI: 10.2147/cia.s3551. View

Pai J, Pischon T, Ma J, Manson J, Hankinson S, Joshipura K . Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351(25):2599-610. DOI: 10.1056/NEJMoa040967. View

Erikssen G, Liestol K, Bjornholt J, Stormorken H, Thaulow E, Erikssen J . Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. Eur Heart J. 2000; 21(19):1614-20. DOI: 10.1053/euhj.2000.2148. View

Saadeh C . The erythrocyte sedimentation rate: old and new clinical applications. South Med J. 1998; 91(3):220-5. View

Danesh J, Muir J, Wong Y, Ward M, Gallimore J, Pepys M . Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J. 1999; 20(13):954-9. DOI: 10.1053/euhj.1998.1309. View

Jia E, Yang Z, Yuan B, Zang X, Wang R, Zhu T . Relationship between leukocyte count and angiographical characteristics of coronary atherosclerosis. Acta Pharmacol Sin. 2005; 26(9):1057-62. DOI: 10.1111/j.1745-7254.2005.00169.x. View

J Blake G, Ridker P . C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol. 2003; 41(4 Suppl S):37S-42S. DOI: 10.1016/s0735-1097(02)02953-4. View

Andresdottir M, Sigfusson N, Sigvaldason H, Gudnason V . Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study. Am J Epidemiol. 2003; 158(9):844-51. DOI: 10.1093/aje/kwg222. View

Berk B, Weintraub W, Alexander R . Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 1990; 65(3):168-72. DOI: 10.1016/0002-9149(90)90079-g. View

10.

Brunetti N, Troccoli R, Correale M, Pellegrino P, Di Biase M . C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol. 2005; 109(2):248-56. DOI: 10.1016/j.ijcard.2005.06.021. View

11.

Gillum R, Mussolino M, Makuc D . Erythrocyte sedimentation rate and coronary heart disease: the NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol. 1995; 48(3):353-61. DOI: 10.1016/0895-4356(94)00156-k. View

12.

Natali A, LAbbate A, Ferrannini E . Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J. 2003; 24(7):639-48. DOI: 10.1016/s0195-668x(02)00741-8. View

13.

Reinhart W . [Erythrocyte sedimentation rate--more than an old fashion?]. Ther Umsch. 2006; 63(1):108-12. DOI: 10.1024/0040-5930.63.1.108. View

14.

Madjid M, Awan I, Willerson J, Casscells S . Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004; 44(10):1945-56. DOI: 10.1016/j.jacc.2004.07.056. View

15.

Pearson T, Mensah G, Alexander R, Anderson J, Cannon 3rd R, Criqui M . Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107(3):499-511. DOI: 10.1161/01.cir.0000052939.59093.45. View

16.

Mendall M, Strachan D, Butland B, Ballam L, Morris J, Sweetnam P . C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000; 21(19):1584-90. DOI: 10.1053/euhj.1999.1982. View

17.

Neumann F, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M . Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995; 92(4):748-55. DOI: 10.1161/01.cir.92.4.748. View